DE69200179T2 - Thioxanthenon-Antitumormittel. - Google Patents

Thioxanthenon-Antitumormittel.

Info

Publication number
DE69200179T2
DE69200179T2 DE69200179T DE69200179T DE69200179T2 DE 69200179 T2 DE69200179 T2 DE 69200179T2 DE 69200179 T DE69200179 T DE 69200179T DE 69200179 T DE69200179 T DE 69200179T DE 69200179 T2 DE69200179 T2 DE 69200179T2
Authority
DE
Germany
Prior art keywords
alkyl
hydrogen
ch2n
thioxanthenones
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69200179T
Other languages
English (en)
Other versions
DE69200179D1 (de
Inventor
Theodore Charles Miller
Joseph Charles Collins
Mark Philip Wentland
Robert Bruno Perni
Thomas Hughes Corbett
Kenneth Charles Mattes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sterling Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Winthrop Inc filed Critical Sterling Winthrop Inc
Application granted granted Critical
Publication of DE69200179D1 publication Critical patent/DE69200179D1/de
Publication of DE69200179T2 publication Critical patent/DE69200179T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655363Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a six-membered ring
    • C07F9/655372Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/10Dibenzothiopyrans; Hydrogenated dibenzothiopyrans
    • C07D335/12Thioxanthenes
    • C07D335/14Thioxanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D335/16Oxygen atoms, e.g. thioxanthones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69200179T 1991-06-10 1992-06-03 Thioxanthenon-Antitumormittel. Expired - Fee Related DE69200179T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71317391A 1991-06-10 1991-06-10
US83515992A 1992-02-13 1992-02-13

Publications (2)

Publication Number Publication Date
DE69200179D1 DE69200179D1 (de) 1994-07-14
DE69200179T2 true DE69200179T2 (de) 1995-01-19

Family

ID=27108950

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69200179T Expired - Fee Related DE69200179T2 (de) 1991-06-10 1992-06-03 Thioxanthenon-Antitumormittel.

Country Status (20)

Country Link
EP (1) EP0518414B1 (de)
JP (1) JP3045354B2 (de)
KR (1) KR100209826B1 (de)
AT (1) ATE106882T1 (de)
AU (1) AU642596B2 (de)
CA (1) CA2070120C (de)
DE (1) DE69200179T2 (de)
DK (1) DK0518414T3 (de)
ES (1) ES2055635T3 (de)
FI (1) FI114024B (de)
HU (1) HU218655B (de)
IE (1) IE66828B1 (de)
IL (1) IL102139A (de)
MX (1) MX9202753A (de)
NO (1) NO302364B1 (de)
NZ (1) NZ242862A (de)
PH (1) PH30883A (de)
RU (1) RU2075477C1 (de)
SG (1) SG50625A1 (de)
TW (1) TW218015B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346917A (en) * 1991-06-10 1994-09-13 Sterling Winthrop Inc. Thioxanthenone antitumor agents
US5091410A (en) * 1991-06-10 1992-02-25 Sterling Winthrop Inc. Thioxanthenone antitumor agents
US5665760A (en) * 1995-09-18 1997-09-09 Sanofi Winthrop, Inc. Lyophilized thioxanthenone antitumor agents
EP2175854A4 (de) * 2007-07-31 2012-02-29 Univ North Dakota Res Foundation Verbessertes verfahren für die synthese substituierter formylamine und substituierter amine
FR2979823B1 (fr) * 2011-09-13 2013-09-27 Pf Medicament Utilisation du 3-(r)-[3-(2-methoxyphenylthio)-2-(s)-methyl-propyl]amino-3,4-dihydro-2h-1,5-benzoxathiepine pour le traitement du cancer et en particulier pour la prevention et/ou le traitement des metastases cancereuses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3745172A (en) * 1970-10-05 1973-07-10 Sterling Drug Inc 1-(di-(lower-alkyl)aminoalkylamino)-9-oxothioxanthenes
US4539412A (en) * 1982-07-08 1985-09-03 Rensselaer Polytechnic Institute 7-Hydroxylucanthone, 7-hydroxhycanthone and their analogs
US5091410A (en) * 1991-06-10 1992-02-25 Sterling Winthrop Inc. Thioxanthenone antitumor agents

Also Published As

Publication number Publication date
IL102139A (en) 1997-03-18
NZ242862A (en) 1993-09-27
NO922273D0 (no) 1992-06-10
HU218655B (hu) 2000-10-28
FI922694A0 (fi) 1992-06-10
IE66828B1 (en) 1996-02-07
NO302364B1 (no) 1998-02-23
DK0518414T3 (da) 1994-08-15
CA2070120A1 (en) 1992-12-11
FI114024B (fi) 2004-07-30
IE921871A1 (en) 1992-12-16
HU9201926D0 (en) 1992-08-28
IL102139A0 (en) 1993-01-14
JPH05178853A (ja) 1993-07-20
AU1704692A (en) 1992-12-17
MX9202753A (es) 1993-01-01
CA2070120C (en) 2005-11-15
TW218015B (de) 1993-12-21
ES2055635T3 (es) 1994-08-16
AU642596B2 (en) 1993-10-21
EP0518414A1 (de) 1992-12-16
ATE106882T1 (de) 1994-06-15
KR100209826B1 (ko) 1999-07-15
KR930000499A (ko) 1993-01-15
HUT61992A (en) 1993-03-29
FI922694A (fi) 1992-12-11
SG50625A1 (en) 1998-07-20
RU2075477C1 (ru) 1997-03-20
PH30883A (en) 1997-12-23
JP3045354B2 (ja) 2000-05-29
NO922273L (no) 1992-12-11
EP0518414B1 (de) 1994-06-08
DE69200179D1 (de) 1994-07-14

Similar Documents

Publication Publication Date Title
PT1178045E (pt) Derivados de azaindole-etilamina como agentes de ligacao de receptores de acetilcolina nicotinicos
TW360652B (en) Acryloyl substituted disstamycin derivatives, process for preparing them, and pharmaceutical composition comprising them
ES2134314T3 (es) Agentes antitumorales de tioxantenona.
DE69200179D1 (de) Thioxanthenon-Antitumormittel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SANOFI, PARIS, FR

8328 Change in the person/name/address of the agent

Free format text: DERZEIT KEIN VERTRETER BESTELLT

8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-SYNTHELABO, PARIS, FR

8328 Change in the person/name/address of the agent

Free format text: MUELLER, SCHUPFNER & GAUGER, 80539 MUENCHEN

8339 Ceased/non-payment of the annual fee